Hisamitsu Pharmaceutical Co Inc - Company Profile
Powered by 
All the data and insights you need on Hisamitsu Pharmaceutical Co Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Hisamitsu Pharmaceutical Co Inc Strategy Report
- Understand Hisamitsu Pharmaceutical Co Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Hisamitsu Pharmaceutical Co Inc (Hisamitsu Pharmaceutical) is a pharmaceutical company that provides pain management products. The company manufactures and sells pain relieving products, dermatological products, and quasi drugs, among others. Hisamitsu Pharmaceutical provides its products in various forms: patches, gel patches, gels, creams, and lotions. Its products are indicated to relieve patients from sore shoulders, arthritis, joint pain backache, strains, sprains, stiff neck, muscle fatigue; bruises, muscle pain, simple backache bruises, stiff shoulders, sprains, strains arthritis, bone fracture, and minor frostbite. It operates production facilities, research laboratories, and offices in Japan. The company markets its products in Asia, Europe, Middle East & Africa, and the Americas. Hisamitsu Pharmaceutical is headquartered in Tosu, Kyushu, Japan.
Headquarters
Japan
Address
30f, Marunouchi Bldg., 2-4-1, Marunouchi, Chiyoda-Ku, Tokyo, 100-6221
Website
www.hisamitsu.co.jp
Telephone
81 3 52931700
No of Employees
2,769
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
4530 (TYO)
Revenue (2023)
$948.1M
10.4%
(2023 vs 2022)
EPS
XYZ
Net Income (2023)
XYZ
19%
(2023 vs 2022)
Market Cap*
$2.1B
Net Profit Margin (2023)
XYZ
7.8%
(2023 vs 2022)
* As of and is in US$
Hisamitsu Pharmaceutical Co Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Anti-Inflammatory Pain Relieving Patches | DermaLight |
| Antifungal Drugs | TransDermaSal |
| Analgesic Drugs | Fentos |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | New Products/Services | In April, the company launched a new pain relief anti-inflammatory plaster “Salonpas Hot” 3 pieces. |
| 2023 | New Products/Services | In March, the company launched an analgesic anti-inflammatory patch Fatus® Z ZIXUS® Ship F 7 packs. |
| 2023 | Contracts/Agreements | In March, the company signed a contract with the Japanese Olympic Committee to support athletes and many people who enjoy citizen sports. |
Competitor Comparison
| Key Parameters | Hisamitsu Pharmaceutical Co Inc | Teva Pharmaceutical Industries Ltd | Daiichi Sankyo Co Ltd | Kaken Pharmaceutical Co Ltd | Zeria Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Israel | Japan | Japan | Japan |
| City | Chiyoda-Ku | Tel Aviv | Chuo-Ku | Bunkyo-Ku | Chuo-Ku |
| State/Province | Tokyo | Tel Aviv | Tokyo | Tokyo | Tokyo |
| No. of Employees | 2,769 | 35,001 | 17,435 | 1,130 | 1,729 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Nobuo Tsutsumi | Director; General Manager- Legal Department, Production Environment, Reliability Assurance, and Compliance | Executive Board | 2014 | - |
| Hisashi Saito | Director; General Manager- International Business Department | Executive Board | - | - |
| Kazuhide Nakatomi | Chief Executive Officer; President | Senior Management | 2022 | - |
| Shinichi Murayama | Director - Internal Control and Domestic Subsidiary | Senior Management | 2014 | - |
| Higo Adult | Senior Managing Executive Officer- Noven Pharmaceuticals | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward